Compounds > 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine

Page last updated: 2024-08-26

1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine and Parkinson Disease

1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine has been researched along with Parkinson Disease in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (25.00)	18.7374
1990's	3 (75.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kondo, T; Mizuno, Y; Nakagawa-Hattori, Y; Yoshino, H	1
Nagatsu, T	1
Bhatti, AR; Devlin, AJ; Ramsden, DB; Williams, AC	1
Iacono, RP; Sandyk, R	1

Reviews

1 review(s) available for 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine and Parkinson Disease

Article	Year
The neurotoxicity of MPTP and its relationship to the pathophysiology of Parkinson's disease. The International journal of neuroscience, 1989, Volume: 44, Issue:1-2 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Humans; MPTP Poisoning; Nervous System; Nervous System Diseases; Parkinson Disease	1989

Other Studies

3 other study(ies) available for 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine and Parkinson Disease

Article	Year
Mitochondrial complex I and II activities of lymphocytes and platelets in Parkinson's disease. Journal of neural transmission. Parkinson's disease and dementia section, 1992, Volume: 4, Issue:1 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Adult; Aged; Aged, 80 and over; Aging; Blood Platelets; Dopamine Agents; Female; Humans; Ketoglutarate Dehydrogenase Complex; Lymphocytes; Male; Middle Aged; Mitochondria; NAD(P)H Dehydrogenase (Quinone); NADH Dehydrogenase; Parkinson Disease	1992
[Parkinson's disease--the molecular mechanism]. Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme, 1990, Volume: 35, Issue:7 Suppl Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amino Acid Sequence; Animals; Base Sequence; Brain Chemistry; DNA; Dopamine; Humans; Molecular Sequence Data; Neurotoxins; Parkinson Disease; Tyrosine 3-Monooxygenase	1990
Inhibition of human benzylamine oxidase (BzAO) by analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Toxicology letters, 1990, Volume: 54, Issue:2-3 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Benzylamine Oxidase; Carbidopa; Dopamine Agents; Humans; Kinetics; Parkinson Disease; Selegiline	1990